O	0	10	Randomized
O	11	16	trial
O	17	19	of
O	20	21	a
B-intervention	22	25	lay
I-intervention	26	32	health
I-intervention	33	40	advisor
I-intervention	41	44	and
I-intervention	45	53	computer
I-intervention	54	66	intervention
O	67	69	to
O	70	78	increase
O	79	90	mammography
O	91	100	screening
O	101	103	in
B-ethinicity	104	111	African
I-ethinicity	112	120	American
O	121	126	women
O	126	127	.

O	128	131	Low
O	131	132	-
O	132	138	income
O	139	146	African
O	147	155	American
O	156	161	women
O	162	166	face
O	167	175	numerous
O	176	184	barriers
O	185	187	to
O	188	199	mammography
O	200	209	screening
O	209	210	.

O	211	213	We
O	214	220	tested
O	221	224	the
O	225	233	efficacy
O	234	236	of
O	237	238	a
O	239	247	combined
O	248	259	interactive
O	260	268	computer
O	269	276	program
O	277	280	and
O	281	284	lay
O	285	291	health
O	292	299	advisor
O	300	312	intervention
O	313	315	to
O	316	324	increase
O	325	336	mammography
O	337	346	screening
O	346	347	.

O	348	350	In
O	351	355	this
O	356	366	randomized
O	366	367	,
O	368	374	single
O	375	380	blind
O	381	386	study
O	386	387	,
O	388	400	participants
O	401	405	were
B-total-participants	406	409	181
O	410	417	African
O	418	426	American
O	427	433	female
O	434	440	health
O	441	447	center
O	448	456	patients
O	457	459	of
O	460	464	ages
B-age	465	467	41
I-age	468	470	to
I-age	471	473	75
I-age	474	479	years
O	479	480	,
O	481	483	at
O	484	485	<
O	486	488	or
O	489	490	=
O	490	493	250
O	493	494	%
O	495	497	of
O	498	505	poverty
O	506	511	level
O	511	512	,
B-eligibility	513	517	with
I-eligibility	518	520	no
I-eligibility	521	527	breast
I-eligibility	528	534	cancer
I-eligibility	535	542	history
I-eligibility	542	543	,
I-eligibility	544	547	and
I-eligibility	548	552	with
I-eligibility	553	555	no
I-eligibility	556	565	screening
I-eligibility	566	575	mammogram
I-eligibility	576	578	in
I-eligibility	579	582	the
I-eligibility	583	587	past
I-eligibility	588	590	15
I-eligibility	591	597	months
O	597	598	.

O	599	603	They
O	604	608	were
O	609	617	assigned
O	618	620	to
O	621	627	either
O	628	629	(
O	629	630	a
O	630	631	)
O	632	633	a
O	634	637	low
O	637	638	-
O	638	642	dose
B-control	643	653	comparison
I-control	654	659	group
O	660	670	consisting
O	671	673	of
O	674	675	a
O	676	686	culturally
O	687	698	appropriate
O	699	710	mammography
O	711	720	screening
O	721	729	pamphlet
O	730	732	or
O	733	734	(
O	734	735	b
O	735	736	)
O	737	748	interactive
O	748	749	,
O	750	758	tailored
O	759	767	computer
O	768	779	instruction
O	780	782	at
O	783	791	baseline
O	792	795	and
O	796	800	four
O	801	808	monthly
O	809	812	lay
O	813	819	health
O	820	827	advisor
O	828	838	counseling
O	839	847	sessions
O	847	848	.

B-outcome-Measure	849	853	Self
I-outcome-Measure	853	854	-
I-outcome-Measure	854	862	reported
I-outcome-Measure	863	872	screening
I-outcome-Measure	873	877	data
O	878	882	were
O	883	892	collected
O	893	895	at
O	896	904	baseline
O	905	908	and
O	909	910	6
O	911	917	months
O	918	921	and
O	922	930	verified
O	931	933	by
O	934	941	medical
O	942	948	record
O	948	949	.

O	950	953	For
O	954	960	intent
O	960	961	-
O	961	963	to
O	963	964	-
O	964	969	treat
O	970	978	analysis
O	979	981	of
O	982	989	primary
O	990	997	outcome
O	998	999	(
O	999	1006	medical
O	1007	1013	record
O	1013	1014	-
O	1014	1022	verified
O	1023	1034	mammography
O	1035	1044	screening
O	1044	1045	,
O	1046	1055	available
O	1056	1058	on
O	1059	1062	all
O	1063	1066	but
O	1067	1070	two
O	1071	1083	participants
O	1083	1084	)
O	1084	1085	,
O	1086	1089	the
O	1090	1102	intervention
O	1103	1108	group
O	1109	1112	had
B-outcome	1113	1122	increased
I-outcome	1123	1132	screening
O	1133	1135	to
B-iv-bin-percent	1136	1138	51
I-iv-bin-percent	1138	1139	%
O	1140	1141	(
B-iv-bin-abs	1141	1143	45
O	1144	1146	of
B-intervention-participants	1147	1149	89
O	1149	1150	)
O	1151	1159	compared
O	1160	1164	with
B-cv-bin-percent	1165	1167	18
I-cv-bin-percent	1167	1168	%
O	1169	1170	(
B-cv-bin-abs	1170	1172	16
O	1173	1175	of
B-control-participants	1176	1178	90
O	1178	1179	)
O	1180	1183	for
O	1184	1187	the
O	1188	1198	comparison
O	1199	1204	group
B-outcome	1205	1207	at
I-outcome	1208	1209	6
I-outcome	1210	1216	months
O	1216	1217	.

O	1218	1222	When
O	1223	1231	adjusted
O	1232	1235	for
O	1236	1246	employment
O	1247	1253	status
O	1253	1254	,
O	1255	1265	disability
O	1265	1266	,
O	1267	1272	first
O	1272	1273	-
O	1273	1279	degree
O	1280	1289	relatives
O	1290	1294	with
O	1295	1301	breast
O	1302	1308	cancer
O	1308	1309	,
O	1310	1316	health
O	1317	1326	insurance
O	1326	1327	,
O	1328	1331	and
O	1332	1340	previous
O	1341	1347	breast
O	1348	1356	biopsies
O	1356	1357	,
O	1358	1361	the
O	1362	1374	intervention
O	1375	1380	group
O	1381	1384	was
O	1385	1390	three
O	1391	1396	times
O	1397	1401	more
O	1402	1408	likely
O	1409	1410	(
O	1410	1418	adjusted
O	1419	1427	relative
O	1428	1432	risk
O	1432	1433	,
O	1434	1435	2
O	1435	1436	.
O	1436	1437	7
O	1437	1438	;
O	1439	1441	95
O	1441	1442	%
O	1443	1453	confidence
O	1454	1462	interval
O	1462	1463	,
O	1464	1465	1
O	1465	1466	.
O	1466	1467	8
O	1467	1468	-
O	1468	1469	3
O	1469	1470	.
O	1470	1471	7
O	1471	1472	;
O	1473	1474	P
O	1475	1476	<
O	1477	1478	0
O	1478	1479	.
O	1479	1483	0001
O	1483	1484	)
O	1485	1487	to
O	1488	1491	get
O	1492	1500	screened
O	1501	1505	than
O	1506	1509	the
O	1510	1513	low
O	1513	1514	-
O	1514	1518	dose
O	1519	1529	comparison
O	1530	1535	group
O	1535	1536	.

O	1537	1544	Similar
O	1545	1552	results
O	1553	1557	were
O	1558	1563	found
O	1564	1567	for
O	1568	1572	self
O	1572	1573	-
O	1573	1581	reported
O	1582	1593	mammography
O	1594	1599	stage
O	1600	1602	of
O	1603	1612	screening
O	1613	1621	adoption
O	1621	1622	.

O	1623	1626	The
O	1627	1635	combined
O	1636	1648	intervention
O	1649	1652	was
O	1653	1664	efficacious
O	1665	1667	in
O	1668	1677	improving
O	1678	1689	mammography
O	1690	1699	screening
O	1700	1702	in
O	1703	1706	low
O	1706	1707	-
O	1707	1713	income
O	1714	1721	African
O	1722	1730	American
O	1731	1736	women
O	1736	1737	,
O	1738	1742	with
O	1743	1745	an
O	1746	1756	unadjusted
O	1757	1763	effect
O	1764	1768	size
O	1769	1770	(
O	1770	1778	relative
O	1779	1783	risk
O	1783	1784	,
O	1785	1786	2
O	1786	1787	.
O	1787	1789	84
O	1789	1790	)
O	1791	1804	significantly
O	1805	1811	higher
O	1812	1813	(
O	1813	1814	P
O	1815	1816	<
O	1817	1818	0
O	1818	1819	.
O	1819	1821	05
O	1821	1822	)
O	1823	1827	than
O	1828	1832	that
O	1833	1835	in
O	1836	1844	previous
O	1845	1852	studies
O	1853	1855	of
O	1856	1860	each
O	1861	1873	intervention
O	1874	1879	alone
O	1879	1880	.
